1. Two courses of four weekly infusions of rituximab with or without interferon-α2a: final results from a randomized phase III study in symptomatic indolent B-cell lymphomas. Issue 9 (2nd September 2015) Authors: Kimby, Eva; Östenstad, Björn; Brown, Peter; Hagberg, Hans; Erlanson, Martin; Holte, Harald; Linden, Ola; Johansson, Ann-Sofie; Ahlgren, Tomas; Wader, Karin; Wahlin, Björn Engelbrekt; Delabie, Jan; Sundström, Christer Journal: Leukemia & lymphoma Issue: Volume 56:Issue 9(2015:Sep.) Page Start: 2598 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗